SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001069530-20-000009
Filing Date
2020-03-26
Accepted
2020-03-26 16:05:01
Documents
59
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sava-20191231x10k.htm 10-K 2048629
2 EX-4.2 sava-20191231xex4_2.htm EX-4.2 38249
3 EX-23.1 sava-20191231xex23_1.htm EX-23.1 8779
4 EX-31.1 sava-20191231xex31_1.htm EX-31.1 21305
5 EX-31.2 sava-20191231xex31_2.htm EX-31.2 21469
6 EX-32.1 sava-20191231xex32_1.htm EX-32.1 11757
7 GRAPHIC sava-20191231x10kg001.jpg GRAPHIC 17140
8 GRAPHIC sava-20191231x10kg002.jpg GRAPHIC 56108
9 GRAPHIC sava-20191231x10kg003.jpg GRAPHIC 14894
10 GRAPHIC sava-20191231x10kg004.jpg GRAPHIC 25089
  Complete submission text file 0001069530-20-000009.txt   6012147

Data Files

Seq Description Document Type Size
11 EX-101.INS sava-20191231.xml EX-101.INS 1133301
12 EX-101.SCH sava-20191231.xsd EX-101.SCH 30949
13 EX-101.CAL sava-20191231_cal.xml EX-101.CAL 32394
14 EX-101.DEF sava-20191231_def.xml EX-101.DEF 95194
15 EX-101.LAB sava-20191231_lab.xml EX-101.LAB 291595
16 EX-101.PRE sava-20191231_pre.xml EX-101.PRE 238830
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29959 | Film No.: 20746164
SIC: 2834 Pharmaceutical Preparations